Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex

Pharmacogenomics Journal

Volumn 7, Issue 1, 2007, Pages 56-65

  Haenisch, S ^a,b   Zimmermann, U ^b   Dazert, E ^b   Wruck, C J ^a   Dazert, P ^b   Siegmund, S ^b   Kroemer, H K ^b   Warzok, R W ^b   Cascorbi, I ^a,b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANTINEOPLASTIC AGENT; CYSTEINE; DNA; GLYCINE; ISOLEUCINE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; SERINE; THREONINE; VALINE; XENOBIOTIC AGENT;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CELL STRAIN HEPG2; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DNA DETERMINATION; DRUG ELIMINATION; FEMALE; GENE CONSTRUCT; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY CORTEX; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

CARCINOMA, RENAL CELL; CLONING, MOLECULAR; DNA, NEOPLASM; FEMALE; GENES, REPORTER; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY NEOPLASMS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; ORGANIC ANION TRANSPORTERS; P-GLYCOPROTEIN; POLYMORPHISM, GENETIC; RNA, MESSENGER; RNA, NEOPLASM; TRANSFECTION;

EID: 33847249931     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500403     Document Type: Article

References (47)

1. Borst P, Evers R, Kool M, Wijnholds J. The multidrug resistance protein family. Biochim Biophys Acta 1999; 1461: 347-357.
2. Klein I, Sarkadi B, Varadi A. An inventory of the human ABC proteins. Biochim Biophys Acta 1999; 1461: 237-262.
3. Konig J, Nies AT, Cui Y, Leier I, Keppler D. Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1999; 1461: 377-394.
4. Young AM, Allen CE, Audus KL. Efflux transporters of the human placenta. Adv Drug Deliv Rev 2003; 55: 125-132.
5. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999; 39: 361-398.
6. Schaub TP, Kartenbeck J, Konig J, Vogel O, Witzgall R, Kriz W et al. Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J Am Soc Nephrol 1997; 8: 1213-1221.
7. Schaub TP, Kartenbeck J, Konig J, Spring H, Dorsam J, Staehler G et al. Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. J Am Soc Nephrol 1999; 10: 1159-1169.
8. Cui Y, Konig J, Buchholz JK, Spring H, Leier I, Keppler D. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug rsistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol 1999; 55: 929-937.
9. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976; 455: 152-162.
10. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A et al. Functional polymorphisms of the human multidrug-resitance gene: multiple sequence variations and correlation of one allele with p-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000; 97: 3473-3478.
11. Johne A, Kopke K, Gerloff T, Mai I, Rietbrock, Meisel C et al. Modulation of steady-state kinetics of digoxin by haplotype of the P-glycopotein MDR1 gene. Clin Pharmacol Ther 2002; 72: 584-594.
12. Verstuyft C, Schwab M, Schaeffeler E, Kerb R, Brinkmann U, Jaillon P et al. Digoxin pharmacokinetics and MDR1 genetic polymorphisms. Eur J Clin Parmacol 2003; 58: 809-812.
13. Wang D, Johnson AD, Papp AC, Kroetz DL, Sadee W. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Genom 2005; 15; 693-704.
14. Uwai Y, Masuda S, Goto M, Motohashi H, Saito H, Okuda M et al. Common single nucleotide polymorphims of the MDR1 gene have no influence on its mRNA expression level of normal kiidney cortex and renal cell carcinoma ian Japanese nephrectomized patients. J Hum Genet 2004; 49: 40-45.
15. Siegmund M, Brinkmann U, Schaffeler E, Weirich G, Schwab M, Eichelbaum M et al. Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptability to renal epithelial tumors. J Am Soc Nephrol 2002; 13: 1847-1854.
16. Motze RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med 1996; 335: 865-875.
17. Storkel S, van den BE. Morphological classification of renal cancer. World J Urol 11995; 3: 153-158.
18. Brauch H, Weirich G, Hornauer MA, Storkel S, Wohl T, Bruning T. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. J Natl Cancer int 1999; 91: 854-861.
19. Bruning T, Weirich G, Hornauer MA, Hofler H, Brauch H. Renal cell carcinoma in tichloroethene (TRI) exposed perons are associated with somatic mutations in the von Hippel-Lindau (VHL) tumour suppressor gene. Arch Toxicol 1997; 71: 332-335.
20. Dhote R, Pellicer-Coeuret M, Thiounn N, Debre B, Vidal-Trecan G. Risk factors for adult renal cell carcinoma: A systematic review and implication for prevention. BJU Int 2000; 86: 20-27.
21. Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M et al. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transpoter MDR1 gene in white subjects. Clin Pharmacol Ther 200; 69: 169-174.
22. Taniguchi S, Mochida Y, Uchiumi T, Tahira T, Hayashi K, Takagi K et al. Genetic polymorphism at the 5′ regulatory region of multidrug resistance 1 (MDR1) and its association with interindiviidual variation of expression level in the colon. Mol Cancer Ther 2003; 2: 1351-1359.
23. Meissner K, Sperker B, Karsten C, Zu Schwabedissen HM, Seeland U, Bohm M et al. Expression and localization of P-glycoprotein in human heart: effects of cardiomyopathy. J Histochem cytochem 2002; 50: 1351-1356.
24. Vogelgesang S, Kunert-Keil C, Cascorbi I, Mosyagin I, Chroder E, Runge U et al. Expression of multidrug tansporters in dysembryoplastic neuroepithelial tumors causing intractable epilepsy. Clin Neuropathol 2004; 23: 223-231.
25. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCCH0034.1-RESEARCCH0034.11.
26. Terwilliger JDaOJ. Handbook of Human Genetic Linkage. Johns Hopkins University Press: Baltimore, MD, 1994.
27. Ernest S, Rajaraman S, Megyesi J, Bello-Reuss EN. Expression of MDR1 (multidrug resistance) gene and it protein in normal human kidney. Nephron 1997; 77: 284-289.
28. Maher JM, Cheng X, Slitt AL, Dieter MZ, Klaassen CD. Induction of the multidrug resistance-associated protein family of transpoters by chemical activators of receptor-mediated pathways in mouse liver. Drug Metab Dispos 2005; 33: 956-962.
29. Miller DS. Xenobiotic export pumps, endothelin signaling, and tubular nephrotoxicants - a case of molecular hijacking. J Biochem Mol Toxicol 2002; 16: 121-127.
30. Bauer B, Hartz AM, Fricker G, Miller DS. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol 2004; 66: 413-419.
31. Denson LA, Auld KL, Schiek DS, McClure MH, Mangelsdorf DJ, Karpen SJ. Interleukin-1 beta uppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J Biol Chem 2000; 275: 8835-8843.
32. Miller DS, Sussman CR, Renfro JL. Protein kinase C regulation of p-glycoprotein-mediated xenobiotic secretion in renal proximal tubule. Am J Physiol 1998; 275: F785-F795.
33. Kovacs G, Fuzesi L, Emanual A, Kung HF. Cytogenetics of papillary renal cell tumors. Genes Chromosome Cancer 1991; 3: 349-355.
34. Siegmund W, Ludwig K, Glessmann T, Dazert P, Schroeder E, Sperker B et al. The P-glycoprotein and dispositon of the probe drug talinolol. Clin Parmacol Ther 2002; 72: 572-583.
35. Meissner K, Jedlitschky G, Meyer zu SH, Dazert P, Eckel L, Vogelgesang S et al. Modulation of multudrug resistance P-glycoprotein 1 (ABCB1) expression in human heart hereditary polymorphisms. Pharmacogenetics 2004; 14: 381-385.
36. Nakamura T, Sakaeda T, Horinouchi M, Tamura T, Aoyama N, Shirakawa T et al, effect of the mutation (C3435T) at exon 26 of the duodenal enterocytes of healthy Japanese subjects. Clin Pharmacol Ther 2002; 71: 297-303.
37. Daya DA, Tuite MF. Post-transcriptional gene regulatory mechanisms in eukaryotes: An overview. J Endocrinol 1998; 157: 361-371.
38. Petriz J, Gottesman MM, Aran JM. An MDR-EGFP gene fusion allows for direct cellular localization, function and stability assessment of P-glycoprotein. Curr Drug deliv 2004; 1: 43-56.
39. Fellay J, Marzolini C, Meaden ER, Back DJ, Buclin T, Chave JP et al. Response to antiretroviral treatment in HIV-1 -infected individuals with allelic variants of the multidrug resistance transporter 1: A pharmacogenetics study. Lancet 2002; 359: 30-36.
40. Hitzl M, Drescher S, van De KH, Schaffeler E, Fischer J, Schwab M et al. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics 2001; 11: 293-298.
41. Kim RB. MDR1 single nucleotide polymorphisms: Multiplicity of haplotypes and functional consequences. Pharmacogenetics 2002; 12: 425-427.
42. Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, Schwarz UI et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther 2001; 70: 189-199.
43. Ito S, Ieiri I, Tanabe M, Suzuki A, Higuchi S, Otsubo K. Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. Pharmacogenetics 2001; 11: 175-184.
44. Itoda M, Saito Y, Soyama A, Saeki M, Murayama N, Ishida S et al. Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: An association between single nucleotide polymorphisms in the 5′-untranslated region and exon 28. Drug Metab Dispos 2002; 30: 363-364.
45. Popowski K, Sperker B, Kroemer HK, John U, Laule M, Stangl K et al. Functional significance of a hereditary adenine inertion variant in the 5′-UTR of the endothelin-1 gene. Pharmacogenetics 2003; 13: 445-451.
46. Geier A, Mertens PR, Gerloff T, Dietrich CG, En-Nia A, Kullak-Ublick GA et al. Constitutive rat multidrug-resistance protein 2 gene transcription is down-regulated by Y-box protein 1. biochem Biophys Res Commmun 2003; 309: 612-618.
47. del Moral RG, Olmo A, Aguilar M, O'Valle F. P-glycoprotein: A new mechanism to contol drug-induced nephrotoxicity. Exp Nephrol 1998; 6: 89-97.